Matches in SemOpenAlex for { <https://semopenalex.org/work/W2571513482> ?p ?o ?g. }
- W2571513482 endingPage "e0169128" @default.
- W2571513482 startingPage "e0169128" @default.
- W2571513482 abstract "Acute myeloid leukemia (AML) is a heterogeneous group of hematopoietic stem cell disorders characterized by defects in myeloid differentiation and increased proliferation of neoplastic hematopoietic precursor cells. Outcomes for patients with AML remain poor, highlighting the need for novel treatment options. Aberrant epigenetic regulation plays an important role in the pathogenesis of AML, and inhibitors of DNA methyltransferase or histone deacetylase (HDAC) enzymes have exhibited activity in preclinical AML models. Combination studies with HDAC inhibitors plus DNA methyltransferase inhibitors have potential beneficial clinical activity in AML, however the toxicity profiles of non-selective HDAC inhibitors in the combination setting limit their clinical utility. In this work, we describe the preclinical development of selective inhibitors of HDAC1 and HDAC2, which are hypothesized to have improved safety profiles, for combination therapy in AML. We demonstrate that selective inhibition of HDAC1 and HDAC2 is sufficient to achieve efficacy both as a single agent and in combination with azacitidine in preclinical models of AML, including established AML cell lines, primary leukemia cells from AML patient bone marrow samples and in vivo xenograft models of human AML. Gene expression profiling of AML cells treated with either an HDAC1/2 inhibitor, azacitidine, or the combination of both have identified a list of genes involved in transcription and cell cycle regulation as potential mediators of the combinatorial effects of HDAC1/2 inhibition with azacitidine. Together, these findings support the clinical evaluation of selective HDAC1/2 inhibitors in combination with azacitidine in AML patients." @default.
- W2571513482 created "2017-01-13" @default.
- W2571513482 creator A5000011620 @default.
- W2571513482 creator A5000604617 @default.
- W2571513482 creator A5013994463 @default.
- W2571513482 creator A5023689602 @default.
- W2571513482 creator A5031313949 @default.
- W2571513482 creator A5039985831 @default.
- W2571513482 creator A5056490394 @default.
- W2571513482 creator A5058330483 @default.
- W2571513482 creator A5072454016 @default.
- W2571513482 date "2017-01-06" @default.
- W2571513482 modified "2023-09-25" @default.
- W2571513482 title "Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia" @default.
- W2571513482 cites W1484293540 @default.
- W2571513482 cites W1504303645 @default.
- W2571513482 cites W1600365609 @default.
- W2571513482 cites W1929971916 @default.
- W2571513482 cites W1963557715 @default.
- W2571513482 cites W1964044574 @default.
- W2571513482 cites W1967018540 @default.
- W2571513482 cites W1967189660 @default.
- W2571513482 cites W1967434207 @default.
- W2571513482 cites W1970990212 @default.
- W2571513482 cites W1971593803 @default.
- W2571513482 cites W1977440531 @default.
- W2571513482 cites W1977723530 @default.
- W2571513482 cites W1978902427 @default.
- W2571513482 cites W1982768428 @default.
- W2571513482 cites W1984731449 @default.
- W2571513482 cites W1988762859 @default.
- W2571513482 cites W1989336886 @default.
- W2571513482 cites W1990814650 @default.
- W2571513482 cites W1991858306 @default.
- W2571513482 cites W1992220938 @default.
- W2571513482 cites W1997671473 @default.
- W2571513482 cites W1997842655 @default.
- W2571513482 cites W1999580244 @default.
- W2571513482 cites W2003173822 @default.
- W2571513482 cites W2004615717 @default.
- W2571513482 cites W2004737765 @default.
- W2571513482 cites W2006229882 @default.
- W2571513482 cites W2009121506 @default.
- W2571513482 cites W2012915254 @default.
- W2571513482 cites W2016849135 @default.
- W2571513482 cites W2026694991 @default.
- W2571513482 cites W2027989872 @default.
- W2571513482 cites W2032230630 @default.
- W2571513482 cites W2033780602 @default.
- W2571513482 cites W2034244318 @default.
- W2571513482 cites W2036407435 @default.
- W2571513482 cites W2038248421 @default.
- W2571513482 cites W2040146704 @default.
- W2571513482 cites W2040257851 @default.
- W2571513482 cites W2040852160 @default.
- W2571513482 cites W2043124942 @default.
- W2571513482 cites W2046091686 @default.
- W2571513482 cites W2048267487 @default.
- W2571513482 cites W2055085859 @default.
- W2571513482 cites W2059002036 @default.
- W2571513482 cites W2062948859 @default.
- W2571513482 cites W2075841564 @default.
- W2571513482 cites W2079806903 @default.
- W2571513482 cites W2082796793 @default.
- W2571513482 cites W2083784041 @default.
- W2571513482 cites W2086773167 @default.
- W2571513482 cites W2086990980 @default.
- W2571513482 cites W2087390915 @default.
- W2571513482 cites W2087834240 @default.
- W2571513482 cites W2094703195 @default.
- W2571513482 cites W2096330673 @default.
- W2571513482 cites W2096367061 @default.
- W2571513482 cites W2096439168 @default.
- W2571513482 cites W2101892777 @default.
- W2571513482 cites W2106833395 @default.
- W2571513482 cites W2109972881 @default.
- W2571513482 cites W2111593849 @default.
- W2571513482 cites W2121610508 @default.
- W2571513482 cites W2129943574 @default.
- W2571513482 cites W2130410032 @default.
- W2571513482 cites W2132682917 @default.
- W2571513482 cites W2139291163 @default.
- W2571513482 cites W2140523553 @default.
- W2571513482 cites W2140908643 @default.
- W2571513482 cites W2141865164 @default.
- W2571513482 cites W2141882676 @default.
- W2571513482 cites W2144110273 @default.
- W2571513482 cites W2144724079 @default.
- W2571513482 cites W2149370967 @default.
- W2571513482 cites W2151089955 @default.
- W2571513482 cites W2154043377 @default.
- W2571513482 cites W2154097321 @default.
- W2571513482 cites W2154358839 @default.
- W2571513482 cites W2155631307 @default.
- W2571513482 cites W2157228274 @default.
- W2571513482 cites W2162675774 @default.
- W2571513482 cites W2168448928 @default.
- W2571513482 cites W2169287961 @default.